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bZIP-Type transcription factors CREB and OASIS
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ABSTRACT
One of the master regulators of placental cell fusion
in mammals leading to multi-nucleated syncytio-
trophoblasts is the transcription factor GCMa.
Recently, we proved that the cAMP-driven protein
kinase A signaling pathway is fundamental for
up-regulation of GCMa transcript levels and pro-
tein stability. Here, we show that Transducer of
Regulated CREB activity (TORC1), the human
co-activator of cAMP response element-binding
protein (CREB), but not a dominant-negative CREB
mutant, significantly up-regulates the GCMa promo-
ter. We identified potential cAMP response element
(CRE)-binding sites within the GCMa promoter
upstream of the transcriptional start site. Only the
CRE site at -1337 interacted strongly with CREB in
promoter mapping experiments. The characteriza-
tion of GCMa promoter mutants and additional bZIP-
type family members demonstrated that also old
astrocyte specifically-induced substance (OASIS) is
able to stimulate GCMa transcription. Knockdown
of endogenous CREB or OASIS in BeWo cells
decreased endogenous GCMa mRNA level and
activity. Overexpression of TORC1 or OASIS in
choriocarcinoma cells led to placental cell fusion,
accompanied by placental expression of gap junc-
tion forming protein connexin-43. Further, we show
that CREB expression is replaced by OASIS expres-
sion around E12.5 suggesting that a sequential order
of bZIP-type family members ensures a high rate of
GCMa transcription throughout placentation.
INTRODUCTION
Members of the GCM (glial cells missing; in ﬂies also
named glide=glial cell deﬁcient) proteins constitute a
unique family of transcription factors (1–3). They share a
common biochemical hallmark, a highly conserved zinc-
coordinating DNA binding domain at the amino-terminus
composed of two subdomains each largely consisting of
b-sheets (1,4). Interaction between each GCM DNA
binding domain and an octameric binding motif composed
of 50-ATGCGGGT-30 is mediated by contacts between
amino acid residues of the b-sheets of GCM proteins and
the major groove of double-stranded DNA (5–8).
GCM homologs have been identiﬁed in a wide range of
species and always shown to be involved as master
regulators in key steps of diﬀerentiation processes. As
mammalian GCM members, GCMa/Gcm1 and GCMb/
Gcm2 were reported (5,7,9). GCMa is necessary for the
diﬀerentiation of trophoblasts to syncytiotrophoblasts, a
process required for placental labyrinth formation (10,11).
Accordingly, GCMa knockout mice lack a functional
placental labyrinth layer and die at mid-embryogenesis.
Remarkably, GCMa is the ﬁrst transcription factor
capable of initiating syncytiotrophoblast formation. In
adult mice, additional GCMa expression sites have been
reported in kidney, thymus and brain (12,13). GCMb is
required for the generation of parathyroid glands (14).
Consequently, GCMb knockout mice suﬀer from hypo-
parathyroidism characterized by aﬀected calcium and
phosphate homeostasis.
Recently, several studies reported about the important
question of what mechanisms direct the regulation of
GCMa itself. We and others showed that stimulation of
GCMa transcriptional activity occurs by cAMP/protein
kinase A (PKA) signaling (15,16). Further, we demon-
strated that the rate of GCMa transcription is directly
stimulated by the cAMP/protein kinase A pathway (15).
Moreover, an increase of GCMa protein stability is
attributed to cAMP response element-binding protein
(CREB)-binding protein (CBP)-mediated acetylation (16).
Histone deacetylase 3 turned out to bind and thereby
regulate GCMa transcriptional activity (17). Additionally,
small ubiquitin-like modiﬁer modiﬁcation was shown to
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Having observed that the cAMP/PKA pathway stimulated
the rate of GCMa transcription, we asked how this is
achieved mechanistically. It is well known that transcrip-
tion factors belonging to the bZIP-type family, like CREB,
are modulated by the cAMP/PKA pathway (19). Members
of the ATF/CREB transcription factor family comprise
apart from CREB itself, transcription factors like, p.ex.
CREM, ATF1, ATF2, ATF6, OASIS, Jun, Fos and
C/EBP proteins (20). All CREB family members bind to
conserved cAMP-responsive elements (CRE) composed of
50-TGACGTCA-30, act upon phosphorylation and mod-
ulate as homo- or heterodimers cellular gene expression
in response to growth factor signals (19). Worth mention-
ing is that some members of the ATF/CREB family
like CREB, ATF6 or OASIS strongly favor homodimer-
ization (21). Recently, three potent activators of CREB
family members referred to here as Transducers of Regu-
lated CREB activity (TORC) were identiﬁed by a high-
throughput expression screen (22). TORC1 was shown to
stimulate CREB-dependent transcription via a phosphor-
ylation-independent interaction with CREB (22).
Here, we present data proving that GCMa transcription
is increased by TORC1-dependent stimulation of the
promoter of GCMa. We identiﬁed a number of potential
CRE-sites within the mouse and human GCMa promoter.
We detected TORC1-dependent stimulation of the tran-
scription of GCMa mainly in the presence of the CRE-site
at -1337at the GCMa promoter in mice and the formation
of a complex between a radiolabeled probe containing this
site and CREB protein. Luciferase reporter studies led to
the identiﬁcation of OASIS, another bZIP-type protein,
stimulating the transcription of GCMa in HEK293 and
the choriocarcinomal cell line BeWo. Using chromatin-
immunoprecipitation, we resolved the binding pattern of
CREB and OASIS on the promoter of GCMa in human
and mouse cells. Further, knockdown of endogenous
CREB or OASIS in BeWo cells led to signiﬁcant reduction
of endogenous GCMa transcript amount and activity.
In fact, we could conﬁrm our data in vivo by detecting
GCMa-dependent connexin-43 immunostaining after
transfection of BeWo cells with TORC1 or OASIS.
Finally, we showed that CREB and OASIS are expressed
sequentially during murine placentogenesis.
MATERIALS AND METHODS
Construction of plasmids, mutagenesis of CRE-sites
The promoter of mouse GCMa or parts thereof were
ampliﬁed by PCR using as template DNA extracted
from mouse embryonic stem cells and cloned 50 to the
luciferase gene into pGL2-Basic (Promega) using the
restriction sites KpnI and XhoI to create reporter plas-
mids. The following primers were used: (1) GCM351+
GCM356 (GCMa promoter  4041 to +1959),
(2) GCM361+GCM356 (GCMa promoter  2892 to
+1959), (3) GCM362+GCM356 (GCMa promoter
 1637 to +1959), (4) GCM363+GCM356 ( 396 to
+1959), (5) GCM364+GCM356 (GCMa promoter
+1018 to +1959) (primer sequences are listed in
Supplementary Table 1; for a scheme of constructs see
Figure 1C).
CRE-sites within the mouse GCMa promoter located
at  1337,  1317,  809 and +1578 were mutated by
replacing single bases within the respective luciferase
reporter plasmids mentioned above using a commercial
mutagenesis kit (QuikChange XL Site-Directed
Mutagenesis Kit, Stratagene) with the following primers:
(1) GCM390+GCM391 ( 1337; AC at  1333/ 1332
were replaced by TG), (2) GCM392+GCM393 ( 1317;
AC at  1313/ 1312 were changed to TG),
(3) GCM394+GCM395 ( 809; AC at  805/ 804 were
mutated to TG), (4) GCM450+GCM451 (+1578; AC at
+1582/ 1583 were mutated to TG) (primer sequences are
listed in Supplementary Table 1; see Figure 2B).
The promoter of human GCMa or parts thereof were
ampliﬁed by PCR using as template DNA extracted from
HeLa cells and cloned 50 to the luciferase gene into pGL2-
Basic (Promega) using the restriction sites NheI and XhoI
to create reporter plasmids. The following primers were
used: (1) GCM434+GCM437 (GCMa promoter  3966
to +3197), (2) GCM436+GCM437 (GCMa promoter
 300 to +3197), (3) GCM438+GCM437 (GCMa
promoter +2258 to +3197), (4) GCM443+GCM437
(+2700 to +3197), (primer sequences are listed in
Supplementary Table 1; for a scheme of constructs see
Figure 5E).
MousebZIP-typetranscriptionfactorswereampliﬁedby
RT-PCR from placental or renal 1st strand cDNA using
the following primers: (1) ATF1-1+ATF1-2, (2) ATF2-
1+ATF2-2,(3)ATF4-1+ATF4-2,(4)ATF5-1+ATF5-2,
(5) ATF7-1+ATF7-2, (6) MafK-3+MafK-4, (7) CREB-
H-1+CREB-H-2, (8) CREB-3-1+CREB-3-2, (9)
OASIS-30+OASIS-31, (10) OASIS-30+OASIS-1, (11)
Fos-5+Fos-6, (12) Jun-1+Jun-2, (13) C/EBPa-
5+C/EBPa-6, (14) C/EBPg-1+C/EBPg-2 (primer
sequences are listed in Supplementary Table 1).
Silencing of CREB or OASIS was achieved by use
of plasmid-derived shRNAs. shRNA primers were
designed with the software Sfold (23). For knocking
down gene expression of human CREB (accession
no. NM_004379), complementary primers (CREB19+
CREB20, or CREB25+CREB26; was not eﬀective and
therefore used as scramble) were hybridized and sub-
cloned into pSUPERneoGFP (Oligoengine) using restric-
tion sites HindIII and BglII. For knocking down gene
expression of human OASIS (accession no. NM_052854)
the following complementary primers were used the same
way like for CREB (OASIS4+OASIS5, or
OASIS8+OASIS9; was not eﬀective and therefore used
as scramble). The eﬃciency of knockdown of respective
gene expression at mRNA level was quantiﬁed by a gene
reporter assay. Therefore, a luciferase gene and either
PCR-ampliﬁed CREB (primers CREB-35+CREB-36;
restriction sites PstI, NheI) or OASIS (primers OASIS-16
+OASIS-17; restriction sites XhoI, NheI) encoding
cDNAs were subcloned as bicistronic messages into
pCMX-PL1. At protein level, the eﬃciency of knockdown
of the CREB or OASIS was conﬁrmed by Western blot.
For the generation of in situ riboprobes, OASIS
and CREB fragments were ampliﬁed using primers
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and subloned into pGEM-Teasy (Promega). For genera-
tion of antisense probes both plasmids were linearized
with NdeI and antisense riboprobes were made using T7
polymerase. Sense riboprobes were generated restriction
digesting the CREB-containing plasmid with SacII and
the OASIS-containing plasmid with NcoI and using the
SP6 polymerase. The strategy for generating mGCMa
riboprobes was described (25).
The RFPnls plasmid was constructed in two parts.
Primers RFP5 and RFPNLS_R were used to amplify by
PCR RFP from plasmid pDS-Red N1 (Clontech). Then,
primers S6F and hS6_NLS_R were used to amplify the
nuclear localization signal from human S6 protein from
pCMX-PL1-GFP-Nls (26). The RFP fragment was cloned
into pCR2.1 (Invitrogen) using restriction sites NheI and
EcoRI, while the nls was cloned into the same vector using
NotI and EcoRI. Finally, both fragments were cloned into
NheI/NotI digested pCMV5-T7b (primer sequences are
listed in Supplementary Table 1).
A TORC1 expression construct was obtained from the
mammalian genome collection (accession number
BC028050), HA-CREB and A-CREB have been described
before (27,28).
Tissue culture, transfection, luciferase assay
HEK293 and BeWo cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 10 or 20%
(v/v) fetal calf serum, respectively (FCS, Invitrogen). The
cells were transfected in 60-mm dishes with 1mgo f
luciferase reporter and 0.1mg of CMV-driven expression
vectors using DNA calcium phosphate precipitates or
Superfect (Invitrogen). Where indicated, BeWo cells were
incubated with forskolin (100mM) or cAMP (150mM). At
48h post-transfection, cells were harvested for luciferase
assays as described (29). All experiments were repeated
independently at least three times.
Electrophoretic mobility shift assays and
chromatin-immunoprecipitation
For electrophoretic mobility shift assays, 0.5ng of 32P-
labeled probe were incubated with HEK293 cell extract
which were transiently transfected with an HA-tagged
CREB expression plasmid for 20min on ice in a 20ml
reaction mixture as described using poly[d(IC)] as
unspeciﬁc competitor and 5mM MgCl2 (29). For super-
shift studies 0.5ml of mouse anti-HA antibody (Cell
Signaling Technology) recognizing HA-tagged CREB
was added to the reaction mixture. For competition
studies, 10- to 500-fold excess of competitor was used.
Samples were loaded onto native 4% (w/v) polyacryl-
amide gels and electrophoresed in 0.5 TBE (45mM Tris,
45mM boric acid, 1mM EDTA, pH 8.3) at 120V for
1.5h. Gels were dried and exposed for autoradiography.
Band intensities were analyzed by Scion Image program
(Scion Corporation).
Chromatin-immunoprecipitation was performed such
that cellular protein and genomic DNA from freshly
prepared mouse embryonic stem cell or BeWo cells tran-
siently transfected with T7-tagged OASIS or HA-tagged
CREB by Lipofectamine (Invitrogen) were cross-linked in
1% formaldehyde before chromatin extraction and
sonication to an average fragment length of 300– 600bp.
Immunoprecipitations were performed overnight at 48C
with monoclonal IgG against HA- or T7-tag antibodies
(Cell Signaling Technology). DNA was puriﬁed from
precipitates after crosslink reversal and subjected to PCR.
For detection of the mouse GCMa promoter the following
primers were used in 37 or 40 cycles of standard PCR with
an annealing temperature of 588C: (1) GCM400+
GCM401 ( 3547 refers to  3587 to  3378),
(2) GCM402+GCM403 ( 2608 refers to  2646 to
 2426), (3) GCM404+GCM405 ( 2066 refers to
 2150 to  1872), (4) GCM406+GCM407 ( 1735
refers to  2040 to  1706), (5) GCM408+GCM409
( 1337/ 1317 refers to  1446 to  1241),
(6) GCM410+GCM411 ( 809 refers to  925 to  637),
(7) GCM412+GCM413 (+1578 refers to +1498 to
+1777), (8) GCM428+GCM429 (negative control
 9508 to  9256). For detection of the human GCMa
promoter following primers were employed in 32 or
35 cycles of standard PCR for OASIS or CREB,
respectively: (1) GCM414+GCM415 ( 3894 refers to
 3948 to  3731), (2) GCM416+GCM417 ( 3080 refers
to  3277 to  3009), (3) GCM418+GCM419 ( 2796
refers to  2862 to  2583), (4) GCM420+GCM421
(+1004 refers to +832 to +1108), (5) GCM422+
GCM423 (+2375 refers to +2233 2459), (6)
GCM424+GCM425 (+3187 refers to +2986 to
+3196), (7) GCM426+GCM427 (negative control
 10129 to  9867). All primer sequences are listed in
Supplementary Table 1.
RNA extraction, reverse transcription andlightcycler PCR,
western blot, insitu hybridization
Total RNA was extracted from mouse tissues or cells with
TRIzol reagent (Invitrogen) as described previously (29).
After reverse transcription, cDNA was used in RT-PCR
experiments. Quantitative PCR reactions were performed
using the LightCycler-FastStart DNA Master SYBR
Green kit and the Light-Cycler Thermal Cycle system
(Roche Applied Science) according to the manufacturer’s
instructions with the following primers for murine genes:
(1) OASIS-32+OASIS-33, (2) CREB-17+CREB-18,
(3) Tpbpa-1+Tpbpa-2, (4) b-actin-111+b-actin-112,
and the following primers for human genes:
(1) OASIS-24+OASIS-25, (2) CREB-15+CREB-16,
(3) GCM315+GCM319, (4) hbActin1+hbActin2
(primer sequences are listed in Supplementary Table 1).
For detection of proteins on nitrocellulose membranes
after Western blotting, the following primary antibodies
were used: monoclonal antibodies directed against the
T7-epitope(Novagen),orthehemagglutinin-epitope(Santa
Cruz). Monoclonal antibodies were used at 1:10000.
Horseradish-peroxidase-coupled anti-mouse-Ig was used
assecondaryantibodiesat1:3000dilutiontogetherwiththe
ECL detection system (Amersham).
Extra-embryonic placental tissues from mice at E9.5
were dissected and ﬁxed in 4% paraformaldehyde,
deposited in 12-well plates and hybridized with sense or
3836 Nucleic Acids Research, 2008, Vol. 36, No. 11antisense RNA speciﬁc for OASIS, CREB or GCMa
according to protocols previously described (25).
Immunocytochemistry of BeWo cells
Conﬁguration of gap junctions in BeWo cells was shown
by immunolabeling for connexin43 (Cx43). For immuno-
cytochemistry, 5 10
4 cells were seeded in chamber slides
and transiently transfected with the indicated expression
plasmids. For identiﬁcation of transfected cells, a RFPnls
expression plasmid generated in analogy to a previously
created GFPnls was co-transfected (Becton Dickinson
Biosciences) (26). Thereafter, cells were ﬁxed with 4%
paraformaldehyde and incubated with a rabbit polyclonal
antibody reactive against Cx43 (Chemicon, ﬁnal dilution
1:300), followed by an Alexa 488-conjugated goat anti-
rabbit IgG treatment (Molecular Probes, ﬁnal dilution
1:250). Cell nuclei were stained with DAPI (Boehringer
Mannheim, ﬁnal concentration 1mg/ml). Cells were
analyzed and documented using a Leica inverted micro-
scope (DMIRB) equipped with a cooled MicroMax CCD
camera (Princeton Instruments).
RESULTS
The GCMa promoter isstimulated by
cAMP-PKA-signaling through specific binding
of thebZIP-type transcription factor CREB
Previously, we and others demonstrated that the PKA
pathway acts upstream of GCMa by inducing the
expression of GCMa and by acetylation-mediated stabi-
lization of GCMa protein (15,16). Here, we investigated
how mechanistically the cAMP-PKA pathway is able
to stimulate the rate of GCMa transcription. As
bZIP-type transcription factors like CREB are known to
be stimulated by the cAMP-PKA pathway, we decided to
examine if this holds true for the GCMa promoter (19).
We transfected HEK293 cells with a reporter plasmid
containing the sequence of mouse GCMa (mGCMa) from
position  4041 relative to the transcriptional start site in
front of a luciferase gene together with TORC1, a speciﬁc
positive co-activator of CREB (Figure 1A and C). In fact,
TORC1 was able to stimulate the mGCMa promoter by
12.9-fold, whereas A-CREB, a dominant-negative mutant
of CREB, signiﬁcantly inhibited TORC1-mediated trans-
activation [Figure 1A; (28)]. Next, we transfected a
luciferase reporter plasmid containing six tandemly
arranged GCM binding sites in front of a luciferase gene
into BeWo choriocarcinoma cells which are known for
endogenous human GCMa (hGCMa) expression (30).
As shown before, concomittant treatment of these cells
with either forskolin or cAMP was suﬃcient to stimulate
endogenous hGCMa activity (15). By co-transfection
of TORC1 we detected a signiﬁcantly higher amount of
endogenous hGCMa activity, while co-tranfection of
A-CREB abolished TORC1-mediated higher hGCMa
activity (Figure 1B).
By computational analysis, we identiﬁed several poten-
tial CRE-binding elements within the mGCMa promoter
(Figure 1C). To rule out those sites which are not
stimulatable by CREB, we cloned a number of 50 deletion
mutants of the mGCMa promoter, fused them to a
luciferase reporter and transfected them alone or
together with TORC1 into HEK293 cells (Figure 1D).
The deletion mutant reporter plasmids containing either
 4041,  2892 or  1637 of the mGCMa promoter were all
stimulated by TORC1, while the mutants  396 and
+1018 lack signiﬁcant amounts of luciferase activity
(Figure 1D). Deletion mutant  1637 contained inducible
CRE-binding sites in the area needed for TORC1-
dependent activation. These were located at  1337,
Figure 1. Forskolin, cAMP, and the transcriptional co-activator of the
transcription factor CREB, TORC1, stimulate the promoter of GCMa.
(A) HEK293 cells transfected in duplicate three independent times by a
mGCMa promoter containing luciferase reporter construct (mGCMa-
4041-Luc) together with either an empty expression plasmid or
expressions plasmids containing TORC1, or TORC1 and A-CREB as
indicated. Luciferase activities were measured after 48h. (B) BeWo cells
were transfected in duplicate three independent times with a six GCM-
binding-sites containing luciferase reporter alone or together with
TORC1, or TORC1 and A-CREB. Cells only tranfected with the
luciferase reporter construct were left untreated or further incubated
with forskolin or cAMP. Luciferase activities were measured after 48h.
(C) Upper part of the scheme shows the area between  4041 to the
ATG of the mGCMa promoter. Exons are indicated as black boxes.
Grey circles point to potential CRE-binding sites. The lower part
symbolizes 50 truncated deletion mutants of the mGCMa promoter
which were used for construction of luciferase reporter plasmids.
(D) HEK293 cells were transfected in duplicate three independent times
with luciferase reporter constructs as described in (C).
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ution of these sites to CREB-mediated mGCMa stimula-
tion, we mutated each site separately within the mGCMa
 1637-luc reporter plasmid and performed luciferase and
electrophoretic mobility shift assays (Figure 2A–C). The
reporter plasmid containing a mutated CRE-binding site
at  1317 was still inducible with TORC1 (Figure 2A).
Only if CRE-binding sites  1337 ( 1337 AC-TG) or
 809 ( 809 AC-TG) within the mGCMa promoter were
mutated in respective reporter plasmids and transfected
with TORC1 in HEK293 cells a signiﬁcant decrease of
luciferase activity was observed which was even more
distinct for  1337 AC-TG (Figure 2A). To ﬁnd out if
CREB binds to the sites at  1337,  1317 or  809 within
the mGCMa promoter, we incubated radiolabeled oligo-
nucleotides with HEK293 cell extract transiently trans-
fected with HA-tagged CREB expression plasmid
(Figure 2B). CREB turned out to bind to the oligonucleo-
tide comprised of the CRE-binding site at  1337 of the
mGCMa promoter (Figure 2B and C). If the HA-CREB-
containing lysate was incubated with the mutated
radiolabeled oligonucleotide ( 1337 AC-TG) we failed
to detect any band (Figure 2C). Accordingly, we were able
to super-shift the complex composed of radiolabeled
 1337 oligonucleotide with HA-tagged CREB if we
added an HA-speciﬁc antibody to the reaction mixture
(Figure 2C). In agreement with the reporter assay, a
mutated  1317 oligonuleotide failed to be shifted after
incubation with HA-CREB-containing HEK293 cell
lysate (Figure 2C). Interestingly, by using radiolabeled
oligonucleotide  809 with a HA-tagged CREB-containing
HEK293 cell lysate in electrophoretic mobility shift
assays, we detected a band running close to the complex
between CREB and the radiolabeled oligonucleotide; but
the same band was detected regardless of transient
transfection of HEK293 with an empty CMV or an HA-
CREB containing expression plasmid (Figure 2C). This
complex was only to a very minor part super-shifted by
additional incubation with HA-speciﬁc antibody
Figure 2. CREB binds to the GCMa promoter pre-dominantly at
position  1337. (A) HEK293 cells transfected in duplicate three
independent times with TORC1 and the GCMa  1637-luc reporter
construct (as shown in Figure 1D) or mutations thereof as indicated.
Luciferase activities were measured after 48h. (B) Oligonucleotide
sequences which were used in electrophoretic mobility shift assays
are depicted. Sequences correspond to parts of the mGCMa promoter
which contain potential CRE binding sites and point substitutions
thereof as used in (C) for electrophoretic mobility shift assays.
Additionally, the sequence of an oligonucleotide used a positive control
is shown containing a typical CRE-binding motif. (C) Electrophoretic
mobility shift assay using oligonucleotides as mentioned in (B) and cell
lysate of HEK293 cells transfected with HA-tagged CREB expression
plasmid. The speciﬁcity of the detected bands were conﬁrmed by super-
shifts using HA-speciﬁc antibodies. Note, CREB binds strongly to
 1337 and to a minor extent to  809. (D) Diﬀerent shRNAs were
examined regarding their ability to knockdown the mRNA of CREB
by a luciferase-reporter assay. For that, bicistronic mRNAs bearing a
full-length luciferase cDNA and the full-length cDNA encoding CREB
were created. shCREB19/20 knocked down CREB by more than 90%
on mRNA level. shCREB25/26 did not aﬀect CREB transcription and
served as scramble control. (E) The lack of CREB at protein level was
demonstrated after transient transfection in HEK293 cells by Western
blot. (F, G) HEK293 cells transfected in duplicate three independent
times with the mGCMa  1637-luc reporter construct (as shown in
Figure 1D) or mutations thereof as indicated and empty pSuper
plasmid, CREB-speciﬁc shRNA (shCREB19/20), or dominant-negative
A-CREB. Note, if CRE-binding site  809 was mutated the measured
luciferase activity decreased only down to 90%, while without mutation
it decreased down to 40% (as shown in A).
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unknown endogenous protein and, to a minor amount,
binding of CREB to the radiolabeled oligonucleotide
 809. By using a mutant variant of the radiolabeled
oligonucleotide  809 ( 809 AC-TG) we failed to detect a
respective band (Figure 2C). As control, a radiolabeled
oligonucleotide containing a CRE consensus site com-
plexed HA-tagged CREB and was further super-shifted by
a HA-speciﬁc antibody (Figure 2C). We decided to
establish shRNA constructs to substantiate that CREB
is aﬀecting mGCMa gene regulation by binding to CRE-
binding sites at  1337, and weakly at  809. To this end,
we investigated several shRNA constructs and found one
which signiﬁcantly knocks down CREB on mRNA and
protein level (Figure 2D and E). Now, we transfected
TORC1, CREB-speciﬁc shRNA or the dominant-negative
A-CREB and mGCMa  1637-luc reporter plasmid or
its mutant variant ( 809 AC-TG) (Figure 2F and G).
Both, CREB-speciﬁc shRNA and A-CREB were able
to impair TORC1-speciﬁc stimulation of the mGCMa
 1637-luc reporter plasmid, but less pronounced the
stimulation of mGCMa  1637-luc ( 809 AC-TG)
(Figure 2A and F, G).
To elucidate the binding characteristics of CREB to the
CRE-containing site at  1337 and to conﬁrm that CREB
does not signiﬁcantly interact with the CRE-containing
site  809 within the GCMa promoter we decided to
perform comparative electrophoretic mobility shift assays.
To this end, we investigated the binding abilities of each
oligonucleotide  1337,  809 and consensus CRE by
incubating them with HEK293 cell lysate containing
HA-tagged CREB together with increasing amounts of
unlabeled oligonucleotide competitors (Figure 3A–F). If
we used radiolabeled consensus CRE oligonucleotide,
only increasing amounts of unlabeled consensus CRE
oligonucleotide was able to disturb binding of CREB to
the radiolabeled consensus CRE site indicating that
CREB binds to  1337 with lower aﬃnity (Figure 3A
and B). However, binding of the radiolabeled oligonucleo-
tide  1337 was only signiﬁcantly competed by increasing
amounts of either unlabeled  1337 or consensus CRE
oligonucleotide (Figure 3C and D). Unlabeled oligo-
nucleotide  809 was not able to compete binding of
radiolabeled  1337 (Figure 3C and D). Finally, radi-
olabeled oligonucleotide  809 was demonstrated to bind a
yet unknown protein and little amounts of CREB as
unlabeled  1337 was not able to supress the formation of
a complex composed of protein and oligonucleotide
(Figure 3E and F, see also Discussion). The consensus
CRE oligonucleotides competed only slightly the binding
of radiolabeled  809 (Figure 3F). On the other hand,
increasing amounts of unlabeled oligonucleotide  809
signiﬁcantly abolished binding of radiolabeled  809 to
the unknown protein (Figure 3E and F).
Figure 3. DNA-binding properties of oligonucleotides containing CRE-binding motifs and representing parts of the mGCMa promoter. Comparative
DNA-binding analysis with HA-tagged CREB containing lysate from transiently transfected HEK293 cells and conditions such that oligonucleotides
containing the typical consensus CRE binding site or the CRE binding sites within the mGCMa promoter were used. As competitors the same or one
of the other oligonucleotides were used in a dose-dependent fashion. Conditions were such that in the absence of competitor, 20 30% of the
radioactively labeled probe was in complex with CREB. The competitor-dependent reduction of probe in the complex was determined by
phosphoimager analysis. The graphs summarize the relative level of competition obtained with increasing amounts of each competitor. (A, B) CREB
protein binding to the consensus CRE motif. As competitors increasing amounts (10- to 500-fold) of  1337,  809 or CREB oligonucleotides were
used. (C–F) The same like in (A, B) but with other labeled oligonucleotides as indicated.
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Being intrigued by the identiﬁcation of an additional
CRE-binding site at  809 which pre-dominantly binds
another protein than CREB but is important for upre-
gulation of the mGCMa promoter we investigated
whether other bZIP-type transcription factors could
additionally be involved in mGCMa promoter stimula-
tion. Therefore, we transiently transfected HEK293 cells
with a reporter plasmid containing  4041 of the mGCMa
promoter 50 to a luciferase gene together with each of
several bZIP-type family members alone or in combina-
tion, and measured promoter transcativation (Figure 4A).
In addition to TORC1, only OASIS was able to induce
the mGCMa  4041-luc reporter plasmid but none of the
other CREB family members, like Jun, Fos, CREB3,
CREB-H, ATF1, ATF2, ATF4, ATF5, ATF7, C/EBPa,
C/EBPg and MafK (Figure 4A). To further substantiate
these ﬁnding, we ﬁrst explored if BeWo cells endogenously
express OASIS. Using RT-PCR studies we detected signiﬁ-
cant amounts of endogenously transcribed mRNAs of
hGCMa, CREB and OASIS (Figure 4B). Next, endogen-
ously hGCMa-expressing BeWo cells were transfected
by either a TORC1 or OASIS encoding expression
plasmids, total RNA extracted and realtime RT-PCR
experiments performed (Figure 4C). GCMa mRNA level
were increased in all cases (Figure 4C). If the BeWo cells
were additionally co-transfected with a reporter plasmid
Figure 4. Identiﬁcation of OASIS as an additional CREB family
member binding to the mGCMa promoter. (A) To investigate if other
CREB family members bind to the mGCMa promoter HEK293 cells
were transfected in duplicate three independent times by the mGCMa-
4041-Luc reporter construct (Figure 1A) together with either an empty
expression plasmid or expressions plasmids containing TORC1, OASIS,
Jun, Fos, ATF1, ATF2, ATF4, ATF5, ATF7, CREB H, CREB 3,
MafK, C/EBPa and C/EBPg, as indicated. Luciferase activities were
measured after 48h. Note, only TORC1 and OASIS are able to
stimulate the mGCMa promoter-containing reporter construct.
(B) Total RNA was extracted from BeWo cells, reverse transcribed,
and used with speciﬁc primers for PCR reactions (30 cycles) to prove
that these cells express endogenously CREB, OASIS, and hGCMa.
(C) BeWo cells were transfected with TORC1, or OASIS expression
plasmids, total RNA extracted and realtime RT-PCR performed. Note,
endogenous hGCMa transcription increased after transfection of CREB
or OASIS. (D) By transiently transfecting a plasmid containing six
GCM binding sites arranged in tandem in front of the luciferase gene
(6xgbs-Luc) it was shown that both TORC1 and OASIS are
signiﬁcantly inducing endogenous hGCMa actvity (students t-test,
 P-value <0.05,
  P-value <0.01). (E) BeWo or HEK293 cells were
transiently transfected with an expression plasmid encoding full length
T7-tagged OASIS. Further, HEK293 cells were transfected with an
expression plasmid encoding only the amino-terminal part of T7-tagged
OASIS (control). By Western blot of the respective extracts showed
that over-expressed full length OASIS is cleaved and its transactivation
capacity containing amino-terminal part liberated in both cell types.
(F, G) shRNAs which knock down OASIS were examined as described
(Figure 2D) and their eﬃcacy on the mRNA and protein levels was
ascertained. (H, I) BeWo cells were transiently transfected by an empty
plasmid (Mock) or plasmids encoding shRNAs as indicated. Total
RNAs were extracted and subjected to realtime RT-PCR to prove that
knockdown of endogenous CREB or OASIS ends up in lowered
GCMa transcript amounts. Additional transfection of the same cells
with a six GCM-binding-sites containing luciferase reporter demon-
strated less GCMa activity after knockdown of CREB or OASIS (I).
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luciferase gene (6 GBS-Luc; Figure 4D), we detected
elevated luciferase activities conﬁrming that both, TORC1
and OASIS were able to stimulate endogenous hGCMa
activity (Figure 4D). OASIS was shown to be a bZIP-type
transcription factor with a transmembrane domain that
allows it to associate with the endoplasmic reticulum (ER)
(31). After cleavage at the membrane in response to ER
stress, its cleaved amino-terminal cytoplasmic domain,
which contains the bZip domain, translocates into the
nucleus where it activates the transcription of target genes
thatare mediated byERstress- andcyclic AMP-responsive
elements (31). To ﬁnd out if OASIS is also cleaved in
HEK293 or BeWo cells, we transiently transfected a full
length Oasis containing expression plasmid into the cells,
prepared lysates and investigated if cleaved bZIP-domain
in these lysates is detectable (Figure 4E). In fact, in the
lysates of both cell types the full length OASIS and the
cleaved bZIP-domain were present. To interrogate endo-
genous transcription factor action, we used a shRNA
approach to speciﬁcally attribute endogenous hGCMa
gene regulation by CREB and OASIS. We generated a
number of shRNA constructs and found one which was
able to signiﬁcantly knockdown the expression of OASIS
on mRNA and protein level (Figure 4F and G). Now, we
transiently transfected the CREB- or OASIS-speciﬁc
shRNAs into BeWo cells and showed by quantitative
RT-PCR or luciferase assays as a consequence a subse-
quent down-regulation of both endogenous GCMa tran-
script level and activity (Figure 4H and I).
CREB and OASIS bindat several CRE sites
within themurine and human GCMapromoter
To reveal the proﬁle of CRE-binding sites used by CREB
and OASIS under physiological conditions in human and
mice, a number of chromatin-immunprecipitations were
performed. By computational analysis, potential CRE-
binding sites were also identiﬁed within the human GCMa
promoter (Figure 5A). T7-tagged OASIS or HA-tagged
CREB expression plasmids were transiently transfected
into either mouse embryonic stem cells or choriocarci-
noma BeWo cells. Both cell lines are known to express
GCMa endogenously (30,32). These experiments demon-
strated that in mice OASIS binds to +1578, while CREB
binds to  2066,  1735,  1337/ 1317 and very weakly to
 809 (Figure 5B). To demonstrate the impact of the newly
identiﬁed OASIS-binding site at +1578 we transfected
OASIS and mGCMa +1078-luc reporter plasmid or its
mutant variant ( 1578 AC-TG) into HEK293 cells and
measured reporter activity. In fact, the mutant variant of
the mGCMa +1078-luc reporter plasmid was almost 40%
less active supporting that OASIS binds at +1578 thereby
stimulating mGCMa promoter activity (Figure 5C). In
human choriocarcinoma BeWo cells, CREB and OASIS
interacted with diﬀerent sites within the hGCMa promoter
(Figure 5D). Here, OASIS binds to  3894,  2796, +1004
and +3187 (Figure 5C), whereas CREB only binds at
+3187 and weakly to  2796 (Figure 5D). To further
substantiate that CREB and OASIS binding sites on the
hGCMa promoter are functional, we generated a series of
50 deletions, fused them to a luciferase gene and
investigated their potential to be induced by CREB or
OASIS. We observed that only the reporter plasmid
carrying the human GCMa promoter from  3966 to
+3197 was able to increase signiﬁcantly luciferase activity
(Figure 5E). This promoter fragment carries CRE-binding
sites  3894 and  2796 which according to the ChIP
analysis bind OASIS and CREB (weak band, see
Figure 5D), respectively. These data prove that OASIS
is an additional bZIP-type family member stimulating the
expression of GCMa, but it is not the unknown
endogenous CREB family member which interacts with
 809at the mGCMa promoter (see also Discussion).
TORC1 and OASIS stimulate endogenous GCMa
expression in BeWocells followed by connexin-43
expression and functionalcell differentiation
To further conﬁrm the role of OASIS and CREB in
GCMa promoter stimulation in vivo, we decided to
transfect endogenously hGCMa-expressing BeWo cells
and follow functional cell diﬀerentiation by immunocyto-
logical stainings for connexin-43 (Cx43). Cx43 is known to
be stimulated after GCMa-mediated activation of syncy-
tin, a fusogenic protein necessary for syncytiotrophoblast
formation during placentogenesis (15). To detect trans-
fected BeWo cells, we co-transfected a RFPnls expression
plasmid. We observed strong Cx43 immunostaining in
RFPnls-positive BeWo cells only after transfection of
either OASIS or TORC1 (Figure 6). If OASIS or TORC1
were additionally co-transfected with the dominant-
negative variants of GCMa (GCMa220) or CREB
(A-CREB), or respective shRNA plasmids which strongly
knockdown OASIS or CREB (Figures 2D–E and 4F–G),
respectively, we failed to detect strong Cx43 immuno-
staining [Figure 6; (15)]. Additionally, we show that the
amino-terminal part of OASIS carrying its transactivation
capacity is causing by its own stronger Cx43 immuno-
staining. This ﬁnding additionally demonstrates that
OASIS is cleaved the proper way in BeWo cells (see also
Figure 4D).
bZIP-Type transcription factorsCREB and OASIS are
induced consecutively during placentogenesis in mice
To understand the role of the bZIP-type transcription
factors CREB and OASIS in mediating GCMa gene
expression during placentogenesis, we analyzed their
temporal and spatial expression proﬁle in the placenta.
First, we extracted total RNA from the fetal part of the
placenta at diﬀerent embryonic stages, reverse transcribed
them into 1st strand cDNA and used them for quantita-
tive RT-PCR studies. We found highest level of CREB
transcripts at E6.5 to E12.5 (Figure 7A and B). While
CREB transcription signiﬁcantly decreases after E12.5, we
observed elevated transcript amounts for OASIS starting
from E12.5 (Figure 7A and B). To ensure that the same
trophoblast cells express GCMa, CREB and OASIS, we
performed whole mount in situ hybridization experiments
with murine placentae at E9.5 (25). Treatment of the
placentae with CREB- or OASIS-speciﬁc antisense
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speciﬁc antisense riboprobe (Figure 7D). In accordance
with the previous PCR data shown, the intensity of the
OASIS-speciﬁc staining located in the placental labyrinth
was weaker (Figure 7A–D). Finally, murine placentae at
E18.5 were dissected in the placental labyrinth layer
containing mainly syncytiotrophoblast and the layer
composed mostly of spongio- and giant trophoblast
parts, total RNA was extracted and realtime RT-PCR
analysis performed. We proved the quality of this
approach by performing PCR analysis using a syncytio-
trophoblast speciﬁc marker (GCMa) or a spongiotropho-
blast marker (Tpbpa: trophoblast speciﬁc protein alpha)
and detecting bands corresponding to the respective tissue
areas (Figure 7E). We then investigated these RNA
fractions for the amount of CREB or OASIS transcript
by realtime PCR analysis. In fact, we detected 90% more
OASIS then CREB encoding transcripts (Figure 7F).
Figure 5. Chromatin-immunoprecipitation analysis revealed the binding proﬁle of CREB and OASIS on the human and mouse GCMa promoters.
(A) Scheme of the mouse and human GCMa promoter regions. Potential CRE-binding sites (grey circles) and exons (black boxes) are indicated.
Numbers relate to the respective transcriptional start sites. (B) Images from agarose gels after chromatin-immunoprecipitation and PCR analysis
demonstrate that both OASIS and CREB bind to several of the potential CRE-binding sites within the mGCMa promoter. (C) HEK293 cells
transfected in duplicate three independent times with OASIS and the mGCMa +1018-luc reporter construct or mutations thereof as indicated.
Luciferase activities were measured after 48h. (D) The same like in (B) for the hGCMa promoter. (E) Upper parts, scheme symbolizes 5’ truncated
deletion mutants of the hGCMa promoter which were used for construction of luciferase reporter plasmids. Lower part, HEK293 cells were
transfected in duplicate three independent times with luciferase reporter constructs as indicated.
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Our data demonstrate for the ﬁrst time the involvement of
bZIP-type transcription factors in the control of the
GCMa promoter in mice. Previous reports already stated
an increase of GCMa activity (i) after incubation of BeWo
Figure 6. OASIS and TORC1 are able to stimulate endogenous GCMa
transcriptional activity in BeWo cells indicated by expression of the
marker of diﬀerentiation Connexin 43 as determined by immunostain-
ing. Transfection of BeWo cells with either OASIS, the amino-terminal
part of OASIS or TORC1 expression plasmids induced functional
diﬀerentiation as depicted by immunocytochemical detection of gap
junctional protein Connexin 43 (Cx43). Co-transfection of either
GCMa220, a dominant-negative type of GCMa, together with OASIS
or A-CREB together with TORC1 inhibits expression of Connexin 43.
The same way, co-transfection of OASIS or CREB-speciﬁc shRNAs
lead to a lowered Connexin 43 immunostaining. Note, a RFPnls
expression plasmid was always co-transfected to enable identiﬁcation of
transfected cells.
Figure 7. Temporal and spatial expression proﬁle of CREB and OASIS
in murine placentae. (A) Agarose gel electrophoresis of ampliﬁed
transcripts of OASIS, CREB and b-actin after RT-PCR using total
RNA extracted from placentae of the indicated age (E6.5–E16.5).
(B, C) Realtime PCR analysis of transcriptional proﬁles of CREB and
OASIS at diﬀerent developmental stages of murine placenta. Values in
graph show gene expression levels of the indicated genes after
normalization with b-actin. Note, the transcript amount of CREB is
highest from E6.5 to E12.5, while OASIS increases starting E12.5.
(D) Whole mount in situ hybridization of placentae at E9.5 labeled with
antisense riboprobes speciﬁc for CREB, OASIS and GCMa. No
staining was detected by sense riboprobes (data not shown).
(E) Placentae at E18.5 were dissected, total RNA extracted from the
labyrinth or the spongio- and giant trophoblast cells containing layer
and used for realtime RT-PCR experiments. Note, the markers
(mGCMa, Tpbpa) are only detectable in RNA from the respective
placental layers. (F) Placental labyrinth layer was used to extract total
RNA for realtime RT-PCR experiments with OASIS- and CREB-
speciﬁc primers.
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transfection of HEK293 cells with mGCMa and a
constitutive active protein kinase A due to an elevated
GCMa protein stability (15,16). Additionally, CREB
binding to the GCMa promoter was identiﬁed by
comprehensive scanning of the human genome (33).
Additionally, it was shown that incubation of BeWo
cells or primary human trophoblasts with cAMP or
forskolin led to an increase in GCMa transcript amounts.
But the question how this mechanistically happens was
remained unsolved (15). Here, we show that TORC1
upregulates the endogenous hGCMa promoter even
stronger than forskolin or cAMP itself (Figure 1B). This
up-regulation of the promoter activity of hGCMa is
speciﬁcally mediated through CREB binding to the
hGCMa promoter because (i) TORC1 is speciﬁcally
upregulating CREB and not any other bZIP-type tran-
scription factor, (ii) the TORC1-mediated transactivation
of a GCMa reporter plasmid can be abolished by a
dominant-negative CREB mutant (A-CREB) which is
known to speciﬁcally inhibit only CREB and (iii) a CREB-
speciﬁc shRNA transfected in BeWo cells decreased
endogenous hGCMa mRNA level and activity.
Furthermore, OASIS, another bZIP-type family member
was, able to stimulate the rate of endogenous hGCMa
transcription and speciﬁcity was veriﬁed knocking down
endogenous OASIS expression by shRNAs which led to
decreased endogenous GCMa mRNA level and activity
(Figure 4). Overexpression of OASIS or CREB failed to
increase the stability of GCMa in HEK293 cells arguing
that higher GCMa activity is solely caused by stronger
GCMa expression (data not shown). Remarkably, we
detected a number of CRE-binding sites within the GCMa
promoter of humans and mice and succeeded in demon-
strating that some of them indeed interact with CREB or
OASIS (Figures 2A–C and 5B–E). The algorithm accord-
ing to which these CRE-sites were searched are based on
structural data about the interaction of CREB with its
binding motif (19). The predicted site at  1317 indeed
functioned by CREB binding. The site at  809 was also
functional, but bound mainly another bZIP-type family
member of unknown identity. In trying to identify its
identity we were, however, able to show that OASIS also
stimulates the GCMa promoter (Figure 4). All our eﬀort
failed to detect any interaction between OASIS and the
GCMa promoter at  809 (data not shown). Further, we
failed to observe a stimulation of ATF1, another CREB
family member, and ATF1 also did not interact with
 809at the GCMa promoter (data not shown).
Although we identiﬁed several CRE-binding sites within
the human and mouse GCMa promoter only some of
them turned out to be functional. This is not surprising
given that not all computationally identiﬁed DNA
sequence motifs have necessarily to be used in gene
regulation. Furthermore, we cannot rule out that some of
these sites are functional in trophoblast cells of living
mice. It is very likely that the repertoire of additional
co-activators of bZIP-type proteins in cultured HEK293
or BeWo cells does not match with trophoblast cells in
human and mice. For example, CREB is thought to be an
important factor for the expression of genes in
trophoblasts and during diﬀerentiation (34). Similar to
nonclassical HLA class I molecule, like HLA-G, the
alpha-subunit of glycoprotein hormone is regulated by
multiple sites including CRE-binding sites (35–37).
However, the tissue-speciﬁc expression of the alpha-
subunit of glycoprotein hormone was controlled by an
additional regulatory element mediating the trophoblast-
speciﬁc expression that is not found in the HLA-G
promoter. This example is evidence for the fact that not
all transcription factor binding sites are necessarily
functional. But functional sites on the genome are often
maintained through evolution consistent with our ﬁnding
that GCMa is regulated by bZIP-type transcription
factors in both species, mouse and human (33).
TORC1 might act in a manner independent of cAMP as
it was shown to be also regulatable by salt inducible kinase
2 (SIK2; a member of the AMPK family) signaling (38).
It might be worth to investigate if SIK2 signaling plays a
role in inducing GCMa expression.
The envelope gene of Human Endogenous RetroVirus
W (HERV-W) syncytin is one of the placental targets of
GCMa (30). It is known that GCMa-mediated stimulation
of syncytin gene expression leads to higher amounts of
trophoblast cell-associated connexin 43 immunoreactivity
(15). Therefore, in order to gain in vivo support for the
biological role of CREB and OASIS we examined if a
higher Cx43 immunoreactivity is detectable in BeWo cells
which were transfected with CREB- or OASIS-encoding
expression plasmids. This was indeed the case. We proved
speciﬁcity by demonstrating failure to increase Cx43
immunoreactivity by co-transfection of dominant-negative
GCMa220 or A-CREB, or by CREB- or OASIS-speciﬁc
shRNA into the same BeWo cells (Figure 6).
OASIS was also shown to be expressed in the placenta
but its role there is unsettled (39). In astrocytes over-
expression of OASIS is associated with the suppression of
ER stress-induced cell death. Dysregulation of ER stress
genes such as OASIS is followed by a loss of protective
cellular responses and eventually cell death (40). Until
now, there are no data available whether the transcription
factor OASIS is involved in such processes in the placenta.
Considering that placental trophoblasts at various stages
of diﬀerentiation exhibit morphological changes, such as
swelling of the mitochondrial intracristal space and ER,
which are related to trophoblastic stress (41), it might well
be that, conversely, the GCMa-dependent expression of
placental fusogenic glycoprotein syncytin-1 serves anti-
apoptotic function under certain conditions, p.ex. lower
activation of caspase 3 in the apoptotic cascade (42).
In fact, the involvement of Cx43 is intriguing, since
Cx43 was reported to contribute via cAMP signaling to
organogenesis and diﬀerentiation of a variety of cellular
systems (43). This might implicate that the stimulation of
GCMa expression in trophoblast cells occurs as an
autoregulation loop such that cAMP signaling stimulates
GCMa expression which in response induces via Cx43
gene expression and cAMP signaling GCMa itself.
Finally, by summarizing these results and reported data
it can be concluded that GCMa activity is regulated at
diﬀerent levels. First, GCMa activity is controlled by its
transcriptional rate through bZIP-type mediated gene
3844 Nucleic Acids Research, 2008, Vol. 36, No. 11regulation (this study). Second, GCMa activity is
increased by stabilizing GCMa protein (15,16). Third,
GCMa activity is modulated through sumoylation (18).
Fourth, GCMa activity is decreased by protein degrada-
tion (44). In addition, GCMa activity might be regulated
by subcellular localization (45).
In total, our data demonstrate that an intricate network
of bZIP-type transcription factors regulates the GCMa
promoter. Further experiments are required to understand
the temporal and sequential pattern of bZIP-type tran-
scription factor action to ensure required GCMa expres-
sion for functional placentogenesis.
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